<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Megakaryocyte volume and platelet production per nucleus in megakaryocyte disorders</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Megakaryocyte volume and platelet production per nucleus in megakaryocyte disorders</h1>
<div class="graphic"><div class="figure"><div class="ttl">Megakaryocyte volume and platelet production per nucleus in megakaryocyte disorders</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Bone marrow analysis was performed in normal subjects and patients with a variety of hematological conditions: hypoplastic bone marrow states (Hypo), B12 deficiency (B12 def), congestive splenomegaly (Congest), immune thrombocytopenia (ITP), chronic inflammation (Inflam), and essential thrombocythemia (ET). Left panel: The amount of megakaryocyte cytoplasm per diploid (2N) amount of nuclear DNA was similar to normal in all of the disorders. Right panel: When the platelet production rate was measured in kinetic studies and then divided by the number of diploid nuclear lobes of the megakaryocyte, the amount of platelets produced per diploid amount of nuclear DNA was normal in all disorders except for hypoplastic marrow states and B12 deficiency in which ineffective thrombopoiesis was present.</div><div class="graphic_reference">Data from: Harker LA, Finch CA. J Clin Invest 1969; 48:963.</div><div id="graphicVersion">Graphic 74204 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
